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Abstract
Background: There is today no established approach to estimate right ventricular ejection fraction (RVEF) using 2D
transthoracic echocardiography (TTE). The aim of this study was to evaluate a new method for RVEF calculations
using 2D TTE and compare the results with cardiac magnetic resonance (CMR) imaging and tricuspid annular plane
systolic excursion (TAPSE).
Methods: A total of 37 subjects, 25 retrospectively included patients and twelve healthy volunteers, were included
to give a wide range of RVEF. The right ventricle (RV) was modeled as a part of an ellipsoid enabling calculation
of the RV volume by combining three distance measurements. RVEF calculated according to the model, RVEFTTE,
were compared with reference CMR-derived RVEF, RVEFCMR. Further, TAPSE was measured in the TTE images and
the correlations were calculated between RVEFTTE, TAPSE and RVEFCMR.
Results: The mean values were RVEFCMR = 43 ± 12% (range 20–66%) and RVEFTTE = 50 ± 9% (range 34–65%). There
was a high correlation (r = 0.80, p < 0.001) between RVEFTTE and RVEFCMR. Bland-Altman analysis showed a mean
difference between RVEFCMR and RVEFTTE of 6 percentage points (ppt) with limits of agreement from −11 to 23 ppt.
The mean value for TAPSE was 19 ± 5 mm and the correlation between TAPSE and RVEFCMR was moderate (r = 0.54,
p < 0.001). The correlation between RVEFTTE and RVEFCMR was significantly higher (p < 0.05) than the correlation
between TAPSE and RVEFCMR.
Conclusions: The ellipsoid model shows promise for RVEF calculations using 2D TTE for a wide range of RVEF,
providing RVEF estimates that were significantly better correlated to RVEF obtained from CMR compared to TAPSE.
Keywords: Right ventricle, Right ventricular function, Echocardiography, Cardiac magnetic resonance imaging
Background
Right ventricular (RV) function is an important predictor
of survival in cardiopulmonary disease [1]. Evaluation of
RV function is therefore essential in both congenital and
acquired heart diseases, such as atrial septal defect, pul-
monary and tricuspid regurgitation, pulmonary hyper-
tension (PH) and arrhythmogenic right ventricular
cardiomyopathy [2–4].
The complex shape of the RV, and the relatively large
element of trabeculations, makes its function more chal-
lenging to assess as compared to the left ventricle (LV),
when using echocardiography. Cardiac magnetic reson-
ance (CMR) imaging is considered to be the reference
method for RV evaluation allowing full ventricular
coverage. In CMR, right ventricular ejection fraction
(RVEF) is often used as a measure of RV function. RVEF
can be determined by calculating the end-diastolic and
end-systolic volumes of the RV in the short-axis (SA)
plane [5]. Previous studies have shown that RVEF pre-
dicts long-term outcome in PH patients for both chil-
dren and adults [6, 7].
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The most common method for RV assessment is, how-
ever, transthoracic echocardiography (TTE) due to its
high availability compared to CMR. A challenge when
using TTE for RV evaluation is the position of the RV
behind the sternum [8]. When imaging the RV in stand-
ard apical four-chamber (4CH) view shadows caused by
a rib or lung often make the RV free wall hard to
visualize, particularly the most apical parts. The absence
of a distinct RV free wall in the TTE image makes fol-
lowing area and volume estimations very uncertain by
both 2D and 3D TTE. For this reason tricuspid annular
plane systolic excursion (TAPSE), also known as tricus-
pid annulus motion (TAM), is often used as a substitute
for RVEF. There are, however, contradictory conclusions
in the literature how well TTE-derived TAPSE correlates
to CMR-derived RVEF. There are examples where the
correlation between TAPSE and RVEF varies from no
correlation [9, 10] to statistically significant correlation
(range 0.45-0.86) [11–13]. Recent guidelines for echocar-
diography still recommend RV assessment by 2D TTE
using multiple acoustic windows, while 3D TTE is only
recommended for laboratories with experience in this
area [14].
Evaluation of the RV using TTE is often made by
the one-dimensional measure of TAPSE along with
quantification of the RV size, often by measuring the
RV diameter, and a visual evaluation of the concentric
movement of the RV free wall. The fact that TTE
provides a real time image of the ventricle function is
an advantage, but the visual assessment might imply
risk of subjectivity. Also, when using TAPSE the ob-
jective evaluation of the RV is only one-dimensional
with a focus on longitudinal movement of the free
wall and potential information may be left out in
terms of global function. The inclusion of more than
one distance measurement in the evaluation of the
RVEF using TTE is a conceivable alternative for
achieving a more consistent measure of RVEF which
relies on a three-dimensional property (volume).
In a previous study, on healthy individuals, we have
presented and evaluated a model for RV volume estima-
tions [15], where the RV is approximated by an ellipsoid
composed of three distances easily measured by TTE.
The results from that study showed that the ellipsoid
model underestimates RV volumes compared to refer-
ence CMR-derived RV volumes, due to underestimation
of distance measurements in TTE compared to CMR.
There was however a good agreement between the el-
lipsoid model derived RVEF and RVEF obtained from
CMR. Since RVEF is calculated as a quota, it is still pos-
sible that this value can be estimated accurately even
though the volumes are underestimated.
The aim of the present study was to evaluate whether
the ellipsoid model can be an alternative to TAPSE for
RVEF estimations by i) estimating the agreement be-
tween RVEF obtained by the ellipsoid model (RVEFTTE)
and reference CMR-derived RVEF (RVEFCMR) and ii)
comparing the correlation for RVEFTTE and TAPSE to




A power analysis was performed to calculate the sample
size needed to detect differences in RVEF of 5 percent-
age points (ppt) between the ellipsoid model and the ref-
erence, with an estimated standard deviation (SD) of 10,
power 80% and α = 0.05. The power analysis concluded a
minimum of 34 subjects.
Study population
Twenty-five patients with reduced RV function, and
examined with both TTE and CMR, were retrospect-
ively included in the study. Patients were identified in
the radiology information system (RIS) using a list of
all CMR examinations performed between January
2012 and May 2015. A subject was included if there
was an entry of a reduced RV function in the clinical
CMR report and a TTE examination had been per-
formed within three months from the CMR examin-
ation. All subjects younger than 18 years were
excluded. The criteria for inclusion in the study was
met if there was a notification of reduced RV func-
tion in the CMR report defined as RVEF <50%,
TAPSE <20 mm or based on visual assessment. The
exact degree of reduced RV function for a specific pa-
tient was not crucial, since to the aim was to get a
variety RVEF. Care was taken to ensure that the pa-
tients had not undergone any cardiac intervention of
significance during the time between CMR and TTE,
such as surgery and treatments including electro-
physiology or potent drugs, which could have influ-
enced on cardiac function. In this regard, care was
also taken to ensure that the loading and filling con-
ditions did not differ significantly between the two
examinations such as heart rate, presence of severe
valve dysfunctions and/or pericardial effusion.
In addition to the 25 patients, the twelve healthy
volunteers from the previous ellipsoid study [15] were
included to ensure a wide range of RVEF. These
twelve examinations were consequently used in both
studies. Characteristics of the subjects are presented
in Table 1.
The Regional Ethical Review Board approved the study
and waived the informed consent requirement for the
retrospectively included patients, while written informed
consent was obtained from the healthy subjects.
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Examinations
The healthy subjects were examined by TTE and CMR
at the same day and location, separated by less than 30
min.
All CMR examinations were performed on a clinical
1.5 T Philips Achieva system (Philips Healthcare, Best,
the Netherlands). A retrospectively triggered balanced
turbo field echo (b-TFE) pulse sequence was used for
the acquisition of conventional images. The following
parameters were applied; TR/TE shortest (typical 3.5
ms/1.7 ms), pixel size typically 1.5x1.5 mm2, flip angle
60°, 1 NSA. For the retrospectively included patients an
acceleration factor (SENSE) of 2 was used, while no ac-
celeration factor was used for the healthy subjects
(SENSE = 1). For the retrospectively included patients
the slice thickness/slice spacing was 5/8 mm and 30
consecutive heart phases were used for the SA images
for all patients but one where 13 consecutive heart
phases were used for the SA images. For the healthy
subjects the slice thickness/slice spacing was 8/8 mm
and 20 consecutive heart phases were used for the SA
images. The protocol applied for examination of patients
was slightly different from the protocol used for the
healthy volunteers. The main reason for this difference
is the adaptation of the protocol to a lower breath hold
ability of the patients compared to healthy volunteers.
The TTE examinations of the group of patients were
performed using three different types of commercial
ultrasound scanners: General Electric Vivid E9 (GE
Vingmed Ultrasound A/S Horten, Norway), Siemens
ACUSON SC2000 (Siemens AG, Germany) or Philips
iE33 (Philips Medical Systems, Andover, MA, USA).
Each system was equipped with a compatible transducer
(phased array and multi-frequency based). The examina-
tions had been carried out as in clinical routine, with the
subjects in the left lateral recumbent position and ECG-
triggering, thus, including digital storage of moving clips
(i.e. cine-loops) from standardized views, allowing offline
measurements. The TTE examinations of the healthy
group were performed solely using one kind of ultra-
sound system (GE Vivid E9). As in clinical routine, these
examinations also included standardized collection pro-
cedure and digital storage of cine-loops (from standard-
ized views).
Ellipsoid model
The RV was approximated by an ellipsoid as previously
described [15]. In short, the ellipsoid model represents
the RV by an ellipsoid composed of three distance mea-
surements available in TTE images; right ventricular in-
flow tract (RVIT3), right ventricular long axis (RVLAX)
and the left ventricular maximum outer basal diameter




 RVIT 3  RVLAX  LVD
For a detailed derivation of the equation see Appendix.
By using this estimate of the RVV, for both diastolic and
systolic measurements, RVEF can be calculated.
Measurements
The distances needed for the ellipsoid model, i.e. RVIT3,
RVLAX and LVD, were measured in diastole and systole
Table 1 Subject characteristics. Parameter values are presented as mean ± SD. Number of subjects is given as a quantity with
the proportion (%) relative all subjects within brackets. Abbreviations: ARVC = arrhythmogenic right ventricular cardiomyopathy,
BMI = body mass index, CMR = cardiac magnetic resonance, n = number, n.a. = not applicable, PH = pulmonary hypertension,
RVEF = right ventricular ejection fraction, TAPSE = tricuspid annular plane systolic excursion, TTE = transthoracic echocardiography
Variables Patients (n = 25) Healthy subjects (n = 12) Overall (n = 37)
Age (year) 55 ± 11 36 ± 12 49 ± 15
BMI [weight(kg)/length(m)2] 27 ± 4 24 ± 4 26 ± 4
Women 5 (20%) 4 (33%) 9 (24%)
RVEF by TTE (ellipsoid model), % 45 ± 7 59 ± 3 50 ± 9
TAPSE by TTE, mm 17 ± 5 22 ± 3 19 ± 5
RVEF by CMR (endocardial delineation in short-axis images and
summation of subvolumes), %
38 ± 10 56 ± 4 43 ± 12
Time difference between CMR and TTE, days 29 ± 26 n.a.(a) n.a.(a)
Absence of significant heart valve disease at TTE(b) 20 (80%) 12 (100%) 32 (86%)
Absence of significant pericardial effusion at TTE(c) 25 (100%) 12 (100%) 37 (100%)
Diagnosed with or suspected primarily right-sided pathology
before or during the current time of study entry(d)
7 (28%) 0 (0%) 7 (19%)
(a) All healthy subjects had CMR and TTE at the same visit (separated by <30 min)
(b) Valve disease defined as significant stenosis and-/or regurgitation (≥ grade 2/3)
(c) Pericardial effusion defined as being recognized with a clear hemodynamic influence
(d) One patient was diagnosed with ARVC, five patients had suspected primarily right-sided pathology and one patient had biventricular dilated cardiomyopathy
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in the stored TTE images (i.e. 2D cine-loops). RVIT3
and RVLAX were measured in apical 4CH view, while
LVD was measured in apical two-chamber (2CH) view
(Fig. 1).
In addition, TAPSE was measured from M-mode TTE
images as obtained in the 4CH view, for all subjects but
one; where M-mode was not available. For this subject,
however, TAPSE was measured in a corresponding 2D
image (by so-called anatomic M-mode feature).
Offline analysis, regarding all of the TTE examinations,
was done using dedicated software (EchoPAC PC, GE
Vingmed Ultrasound). All TTE measurements were cal-
culated as the average of up to three different cardiac cy-
cles, as in clinical routine, with regard to image quality
and the amount of images per view.
In SA CMR images the end-diastolic and end-systolic
volumes were achieved by manually delineating the
endocardium of the right ventricle using the freely avail-
able software Segment version 2.0 R4800 (http://
www.segment.heiberg.se/ [16]. All available stacks with
information of the tricuspid and the pulmonary valves
were used to add information about the valves position
in the SA images to improve the decision of which parts
of the most basal slices to include in the ventricle vol-
ume. Using these end-diastolic and end-systolic volumes
the RVEF was calculated.
The TTE measurements were performed by one bio-
medical scientist with 8 years of experience (observer 1),
and one master of science in biomedical engineering
with 3 years’ of experience in the scientific TTE field but
limited clinical experience (observer 2). The CMR mea-
surements were performed by one radiologist with 4
years of experience (observer3), and one master of
science in biomedical engineering with 5 years’ experi-
ence in the scientific CMR field but limited clinical
experience (observer 2).
Inter-observer (intra-modality) agreement for each
modality was performed.
The mean value for the two observers for each method
was calculated to give RVEFTTE and RVEFCMR. These
mean values were used for the inter-modality agreement
evaluation.
Statistics
Shapiro-Wilk’s test was used to determine normality of
the data. Paired Student’s t-test was used to test the
significance for normally distributed differences, while
Wilcoxon signed-rank test was used for non-normally
distributed differences. Bland-Altman limits of agree-
ment method were used to evaluate the differences [17]
for both normally and non-normally distributed differ-
ences as non-normality does not have a great impact on
the limits of agreement [18]. Pearson’s correlation coeffi-
cient was used to test the correlation between the two
different methods for calculating RVEF and interpreted
as negligible (0 < r < 0.3), low (0.3 < r < 0.5), moderate
Fig. 1 Transthoracic echocardiography distances. Images showing the transthoracic echocardiography distances for a healthy 33 year old male
subject in a) and b) apical 4CH view and in c) apical 2CH view. LA = left atrium, LV = left ventricle, LVD = left ventricular diameter, RA = right
atrium, RV = right ventricle, RVIT3 = right ventricular inflow tract, RVLAX = right ventricular long axis
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(0.5 < r < 0.7), high (0.7 < r < 0.9) and very high (r > 0.9)
[19]. Steiger’s z-test was used to decide whether two cor-
relation coefficients were significantly different or not
[20]. Statistical analyzes were performed using IBM SPSS
Statistics version 22 (IBM Corp., Armonk, NY, USA)
and Stata (version 14.1, StataCorp LP, College Station,
Texas, USA). All values are presented as mean ± 1
SD. p < 0.05 was considered to indicate statistical
significance.
Results
The 25 retrospectively included patients had a mean age
of 55 years (range 27–72 years, 20% women), while the
twelve healthy subjects had a mean age of 36 years
(range 18–65 years, 33% women). The TTE and CMR
examinations for the 25 patients were separated by a
maximum of 77 days (mean 29 days, range 0–77 days)
(Table 1).
There was a high correlation r = 0.80 (p < 0.001) be-
tween RVEFTTE and RVEFCMR, while the correlation be-
tween TAPSE and RVEFCMR was moderate r = 0.54 (p <
0.001) (Fig. 2). The correlation between TAPSE and
RVEFCMR was significantly lower than the correlation
between RVEFTTE and RVEFCMR (p < 0.05). RVEFTTE
obtained from the ellipsoid model was 50 ± 9% (range
34–65) and RVEFCMR was 43 ± 12% (range 20–66).
There was a significant difference between RVEFTTE and
RVEFCMR using Wilcoxon signed rank test (Z = −4.1, p
< 0.001). The mean value for TAPSE was 19 ± 5 mm.
Figure 3 shows the Bland-Altman plot for the difference
between RVEFTTE and RVEFCMR. The standard deviation
for the differences of the mean values in the Bland-
Altman analysis was calculated according to the recom-
mendation for analyzes based on mean values [17].
When the healthy subjects were excluded, the cor-
relation between RVEFTTE and RVEFCMR for the
remaining subgroup of 25 patients was moderate, r =
0.62 (p < 0.01), while the correlation between TAPSE
and RVEFCMR was low, r = 0.34, and could not be sta-
tistically verified. There was a significant difference
(p < 0.001) between RVEFTTE and RVEFCMR for this
subgroup of 8 ± 8 ppt (95% CI: 4.1-11).
The results for the RVEF calculations of each observer
were RVEFTTE obs1 = 47 ± 10 (range 30–65), RVEFTTE
obs2 = 52 ± 9 (range 34–70), RVEFCMR obs2 = 42 ± 14
(range 17–68) and RVEFCMR obs3 = 45 ± 12 (range 18–
63). An additional file contains the RVEF values for each
subject (see Additional file 1). The mean difference be-
tween RVEFTTE obs1 and RVEFTTE obs2 was 6 ± 7 ppt,
while the mean difference between RVEFCMR obs2 and
RVEFCMR obs3 was 2 ± 6 ppt. Both differences were nor-
mally distributed and statistically significant (p < 0.05).
This inter-observer agreement can also be considered as
an intra-modality agreement since they rely on data
from the same modality. The correlation between
RVEFTTE obs1 and RVEFTTE obs2 was high r = 0.73 (p <
0.001), while the correlation between RVEFCMR obs2 and
RVEFCMR obs3 was very high r = 0.91 (p < 0.001).
Discussion
Determination of RVEF is an important parameter in
the assessment of cardiovascular diseases. There is
Fig. 2 Correlation between RVEFCMR, RVEFTTE and TAPSE. The correlation between a) RVEF obtained from the application of the ellipsoid model
using TTE measurements and RVEF derived from CMR imaging and b) the correlation between TAPSE from TTE and RVEF derived from CMR.
CMR = cardiac magnetic resonance, RVEF = right ventricular ejection fraction, TAPSE = tricuspid annular plane systolic excursion,
TTE = transthoracic echocardiography
Jorstig et al. Cardiovascular Ultrasound  (2017) 15:4 Page 5 of 9
today no established method for measurement of
RVEF based on volume estimations using 2D TTE.
The results in this study show that a combination of
three conventional distance measurements in 2D
TTE provides volume-based estimations of RVEF
that strongly correlates to CMR for a clinically rele-
vant range of RVEFs. The distances can easily be
measured in the 2D TTE images and is not
dependent on a complete visualization of the RV free
wall which remains as a challenge in echocardiog-
raphy. The time for measuring the distances neces-
sary for the ellipsoid model is, after some initial
testing at our department, considerably shorter com-
pared to RVEF calculations using 3D TTE data with
post processing software. The ellipsoid model is not
necessarily less time-consuming compared to other
conventional 2D parameters (such as TAPSE, frac-
tional area change, longitudinal strain and strain rate
by Doppler tissue imaging and speckle-tracking
echocardiography (STE)), although it may be recog-
nized with relatively high applicability in this regard;
since it does not require full visualization of the en-
tire RV free wall. The moderate correlation between
TAPSE and RVEFCMR was significantly lower
compared to the high correlation between RVEFCMR
and the RVEF obtained using the ellipsoid model.
This difference in correlation might seem reasonable
since the ellipsoid model combines distances expand-
ing a volume while TAPSE provides a one-directional
estimate.
An upcoming method for RV evaluation is longitu-
dinal STE strain for regional or global analysis of the
RV free wall. STE strain enables quantification of the
RV free wall which, compared to Doppler tissue im-
aging strain, is less angle dependent but the need for
good image quality and full visualization of the RV
free wall is still present [14]. A recent study provided
reference values for RV longitudinal strain (RVLS) by
STE [21]. These reference values for RVLS showed a
weak correlation to RVEF by 3D TTE (0.27 for 6-
segment RVLS and 0.28 for 3-segment RVLS). The
authors discuss the fact that RVLS does not take into
account the radial movement of the RV and that RV
radial strain is difficult to measure by 2D STE [21].
Thus, at the moment this technique does not seem to
add any extra value in this context (in addition to
measuring TAPSE). A comparison between STE strain
and the proposed ellipsoid model, regarding the
Fig. 3 Bland-Altman plot of agreement between RVEFTTE and RVEFCMR. Bland-Altman plot of the agreement between the mean values for RVEF
calculated using the ellipsoid model on TTE measurements and RVEF derived from CMR. The dashed lines show the mean value and the limits of
agreements. CMR = cardiac magnetic resonance, RVEF = right ventricular ejection fraction, TTE = transthoracic echocardiography
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assessment of the RV function, would be of interest
for future studies.
There was a small but significant mean difference
regarding RVEF as estimated with the ellipsoid
model compared to CMR, where the ellipsoid overes-
timates the RVEF. As seen in Figs. 2 and 3 there are
larger differences for low RVEF values compared to
higher values. The limits of agreement in the Bland
Altman analysis are −11 to 23 ppt. This is a rather
wide range for the limits of agreement, but as shown
in Fig. 3 there are six out of the 25 patients which
mainly contribute to the increased mean difference
and limits of agreements. Among these six patients
one was diagnosed with ARVC, while four of them
(of which one was recognized with severe PH)
showed signs of more or less regional RV dilatation;
despite not fulfilling the criteria for ARVC (Table 1).
Thus, the majority of these outliers had a clearly ab-
normal RV morphology, indicating that the ellipsoid
model is less suitable for this category of patients. How-
ever, the ellipsoid model might be used to detect RV dys-
function before it results in RV deformation. For the
remaining 31 subjects however, among which there were
no diagnoses of ARVC, severe PH or signs of abnormal
morphology, the difference is about 10 ppt or lower, which
could be considered as clinically acceptable differences.
The correlation between RVEF estimated by the
ellipsoid model and CMR was lower for the sub-
group of 25 patients compared to the correlation
for all subjects, but still at a moderate level, while
there was no correlation between TAPSE and CMR
for this subgroup. This indicates that the ellipsoid
model provides a better estimate of global RV func-
tion compared to TAPSE. The fact that there were
up to three months between the TTE and CMR ex-
aminations for the patient group is a possible reason
for the greater differences and lower correlation,
along with the issue of abnormal RV morphology dis-
cussed above. Also, the number of subjects and the
distribution of the RVEF-values differ when compar-
ing the correlation coefficient for the subgroup of 25
patients to the correlation coefficient for all 37 sub-
jects. A prospective study, performing CMR and TTE
examinations on the same day for a group of subjects
with a wide range of RVEF values, is needed to fur-
ther evaluate the ellipsoid model.
In TTE, according to our experience, RVEF is quite
often determined by visual estimation of the concentric
movement of the RV free wall, along with TAPSE mea-
surements. We believe that this new method for RVEF
calculations is a way to improve the RVEF estimations
using TTE, and making it less subjective.
Looking at the intra-modality agreement there was a
high correlation for TTE compared to a very high for
CMR. There was a slightly smaller bias and more
narrow limits of agreements for CMR compared to
TTE. This indication, that CMR measurements are
more reproducible, agrees with CMR being consid-
ered to be the reference for such measurements.
Also, the inter-observer variability may be affected
by the difference in clinical experience between the
observers.
CMR and TTE complement each other and a multi-
modality approach is often a good alternative when pos-
sible. We believe, however, that this new method pro-
posed for RVEF calculations using TTE may be of value
when CMR is not possible.
Limitations
One of the dimensions in the ellipsoid model is based
on a left ventricular measure (LVD) and is not a dir-
ect right ventricular measure. This could influence
the accuracy for groups of patients, such as patients
with arrhythmogenic right ventricular cardiomyopathy
(ARVC), due to the risk of an increase of the right
ventricle width in this direction, which not necessarily
leads to an increase of the left ventricular diameter.
Further evaluation of the model’s applicability for this
group of patients is necessary. An alternative to using
the LVD measure in the equation, could be to replace
it with the corresponding measure of the RV in a
basal parasternal short-axis view, possibly resulting in
better agreement also for patients with abnormal RV
morphology.
When measuring RVIT3, the apical 4CH view
should be focused on the RV, as recommended in the
guidelines [14]. For the healthy subjects the RV fo-
cused apical 4CH view was used, while it is not cer-
tain that this was the case for the retrospectively
included patients. This means that there is a risk of
volumetric underestimation regarding the group of
retrospectively included patients. However, since the
RVEF is a quota, this aspect may be considered to be
less significant in the context.
The fact that it was up to three months between the
examinations for the retrospectively included patients
might influence the results.
In this study, CMR is used as reference method. It is the
method commonly used as reference method for ventricu-
lar volume calculations, but it is however important to re-
member that the calculations by CMR also are estimations.
In particular for the RV, delineation of the endocardium is
a difficult task and the true value remains unknown.
Conclusions
The ellipsoid model provides an alternative for RVEF
calculations using 2D TTE that gives a higher correl-
ation to CMR compared to TAPSE for a wide range
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of RVEF. An incomplete visualization of the RV free
wall, which is a common challenge in TTE, is not a
restriction for the application of the method.
Appendix





where a, b and c are the radiuses of the ellipse or
ellipsoid.
Figure 4 shows parts of two ellipsoids with two com-
mon radiuses, b and c. The third radius, a1 and a2 are
not equal. The volume of grey region can be expressed
as the difference between a quarter of the volume of the
larger ellipsoid and a quarter of the volume of the
smaller ellipsoid, i.e.:
Vgrey ¼ πbc3 a2−a1ð Þ
If a2-a1 is approximated by RVIT3, b approximated by
LVD/2 and c approximated by RVLAX, an estimate of
RVV is given by:
RVV ¼ π
6
 RVIT 3  RVLAX  LVD
Additional file
Additional file 1: RVEF calc for each observer. (XLSX 15 kb)
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